Shopping Cart 0
Cart Subtotal
AED 0

Motif Bio Plc (MTFB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Motif Bio Plc (Motif Bio), formerly Motif Bio Ltd, is a clinical-stage biopharmaceutical company that focuses on the development of novel antibiotics to treat patients with infections caused by multi-drug resistant bacteria. The company develops Iclaprim, a targeted Gram-positive1 antibiotic with activity against methicillin-resistant Staphylococcus aureus. Its indications for iclaprim include hospital-acquired bacterial pneumonia (HABP) including ventilator-associated bacterial pneumonia (VABP) and Staphylococcus aureus lung infections in people with cystic fibrosis. The company has operations in the UK and the US. Motif Bio is headquartered in London, the UK.

Motif Bio Plc (MTFB)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Motif Bio Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Motif Bio Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Motif Bio Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Motif Bio Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Motif Bio Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Motif Bio Plc, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

Motif Bio Enters into Agreement with Covance 11

Motif BioSciences Enters Into Co-Development Agreement With Jubilant Biosys 12

Merger 13

Motif Biosciences to Merge with Pharmaceutical Company 13

Equity Offering 14

Motif Bio Raises USD13.5 Million in Private Placement of Shares 14

Motif Bio Raises Funds through Private Placement of Shares up on Exercise of Warrants 15

Motif Bio Raises Funds through Private Placement of Shares up on Exercise of Warrants 16

Motif Bio Files Registration Statement to Raise up to USD80 Million in Public Offering of Securities 17

Motif Bio Files Registration Statement to Raise Funds through Private Placement of ADS upon Exercise of Warrants 18

Motif Bio to Raise USD0.1 Million in Public Offering of Shares up on Exercise of Warrants 19

Motif Bio to Raise USD25 million in Placing of New Ordinary Shares 20

Motif Bio Raises Funds through Private Placement of Shares and Warrants 21

Motif Bio Raises USD17 Million in Public Offering of American Depositary Shares and Warrants 23

Motif Bio Raises Funds through Private Placement upon Exercise of Warrants 25

Motif Bio Raises Funds in Private Placement upon Exercise of Warrants 26

Motif Bio Raises USD35 Million in Private Placement of Shares 27

Motif Bio Raises USD41.8 Million in IPO 28

Debt Offering 29

Motif Bio to Raise USD20 Million in Private Placement of Debt Financing 29

Acquisition 30

Motif BioSciences Acquires Nuprim 30

Motif Bio Plc-Key Competitors 31

Motif Bio Plc-Key Employees 32

Motif Bio Plc-Locations And Subsidiaries 33

Head Office 33

Other Locations & Subsidiaries 33

Recent Developments 34

Financial Announcements 34

Sep 25, 2018: Motif Bio announces Half-Year 2018 financial results and operational progress 34

Apr 10, 2018: Motif Bio Reports Fiscal Year 2017 Results 35

Sep 29, 2017: Motif Bio reports half-year 2017 financial results and operational progress 39

May 01, 2017: Motif Bio Reports Year-End 2016 Financial Results 40

May 01, 2017: Motif Bio annual net loss up 41

Corporate Communications 42

Jul 03, 2018: Motif Bio Announces Resignation of Robert Bertoldi from Board of Directors 42

Feb 02, 2018: Motif Bio Appoints Jonathan E. Gold As Interim Chief Financial Officer 43

May 10, 2017: Motif Bio Appoints Scientific Opinion Leaders to Advisory Board 44

May 05, 2017: Motif Bio Appoints Dr. Craig Albanese as Non-Executive Director 45

Jan 17, 2017: Motif Bio: Appointment of Chief Financial Officer 46

Government and Public Interest 47

Jan 29, 2018: Motif Bio, Spero Therapeutics and Vical Join Antimicrobials Working Group 47

Product News 48

06/22/2017: Motif Bio Invited to Present at Infectious Diseases Conference 48

Clinical Trials 49

Aug 09, 2017: Motif Bio's second Phase 3 clinical trial in ABSSSI finishes patient treatment phase 49

Jul 06, 2017: Motif Bio to Present Three Posters at IDWeek 2017 50

May 01, 2017: Motif Bio Reports Year-end 2016 Financial Results 51

Apr 18, 2017: Motif Bio Announces Positive Results For Iclaprim, In The Revive-1 Phase 3 Study 52

Jan 30, 2017: Motif Bio Phase 3 Clinical Trial Finishes Patient Treatment Phase 53

Other Significant Developments 54

Mar 13, 2018: Motif Bio: Change of Registered Office 54

Appendix 55

Methodology 55

About GlobalData 55

Contact Us 55

Disclaimer 55


List Of Figure

List of Figures

Motif Bio Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Motif Bio Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Motif Bio Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Motif Bio Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Motif Bio Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Motif Bio Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Motif Bio Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Motif Bio Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9


List Of Table

List of Tables

Motif Bio Plc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Motif Bio Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Motif Bio Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Motif Bio Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Motif Bio Plc, Deals By Therapy Area, 2012 to YTD 2018 9

Motif Bio Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Motif Bio Enters into Agreement with Covance 11

Motif BioSciences Enters Into Co-Development Agreement With Jubilant Biosys 12

Motif Biosciences to Merge with Pharmaceutical Company 13

Motif Bio Raises USD13.5 Million in Private Placement of Shares 14

Motif Bio Raises Funds through Private Placement of Shares up on Exercise of Warrants 15

Motif Bio Raises Funds through Private Placement of Shares up on Exercise of Warrants 16

Motif Bio Files Registration Statement to Raise up to USD80 Million in Public Offering of Securities 17

Motif Bio Files Registration Statement to Raise Funds through Private Placement of ADS upon Exercise of Warrants 18

Motif Bio to Raise USD0.1 Million in Public Offering of Shares up on Exercise of Warrants 19

Motif Bio to Raise USD25 million in Placing of New Ordinary Shares 20

Motif Bio Raises Funds through Private Placement of Shares and Warrants 21

Motif Bio Raises USD17 Million in Public Offering of American Depositary Shares and Warrants 23

Motif Bio Raises Funds through Private Placement upon Exercise of Warrants 25

Motif Bio Raises Funds in Private Placement upon Exercise of Warrants 26

Motif Bio Raises USD35 Million in Private Placement of Shares 27

Motif Bio Raises USD41.8 Million in IPO 28

Motif Bio to Raise USD20 Million in Private Placement of Debt Financing 29

Motif BioSciences Acquires Nuprim 30

Motif Bio Plc, Key Competitors 31

Motif Bio Plc, Key Employees 32

Motif Bio Plc, Subsidiaries 33

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Motif Bio Plc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Summary

Motif Bio Plc (Motif Bio), formerly Motif Bio Ltd, is a clinical-stage biopharmaceutical company that focuses on the development of novel antibiotics to treat patients with infections caused by multi-drug resistant bacteria. The company develops Iclaprim, a targeted Gram-positive1 antibiotic with activity against methicillin-resistant Staphylococcus aureus. Its indications for iclaprim include hospital-acquired bacterial pneumonia (HABP) including ventilator-associated bacterial pneumonia (VABP) and Staphylococcus aureus lung infections in people with cystic fibrosis. The company has operations in the UK and the US. Motif Bio is headquartered in London, the UK.

Motif Bio Plc (MTFB)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Motif Bio Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Motif Bio Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Motif Bio Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Motif Bio Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Motif Bio Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Motif Bio Plc, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

Motif Bio Enters into Agreement with Covance 11

Motif BioSciences Enters Into Co-Development Agreement With Jubilant Biosys 12

Merger 13

Motif Biosciences to Merge with Pharmaceutical Company 13

Equity Offering 14

Motif Bio Raises USD13.5 Million in Private Placement of Shares 14

Motif Bio Raises Funds through Private Placement of Shares up on Exercise of Warrants 15

Motif Bio Raises Funds through Private Placement of Shares up on Exercise of Warrants 16

Motif Bio Files Registration Statement to Raise up to USD80 Million in Public Offering of Securities 17

Motif Bio Files Registration Statement to Raise Funds through Private Placement of ADS upon Exercise of Warrants 18

Motif Bio to Raise USD0.1 Million in Public Offering of Shares up on Exercise of Warrants 19

Motif Bio to Raise USD25 million in Placing of New Ordinary Shares 20

Motif Bio Raises Funds through Private Placement of Shares and Warrants 21

Motif Bio Raises USD17 Million in Public Offering of American Depositary Shares and Warrants 23

Motif Bio Raises Funds through Private Placement upon Exercise of Warrants 25

Motif Bio Raises Funds in Private Placement upon Exercise of Warrants 26

Motif Bio Raises USD35 Million in Private Placement of Shares 27

Motif Bio Raises USD41.8 Million in IPO 28

Debt Offering 29

Motif Bio to Raise USD20 Million in Private Placement of Debt Financing 29

Acquisition 30

Motif BioSciences Acquires Nuprim 30

Motif Bio Plc-Key Competitors 31

Motif Bio Plc-Key Employees 32

Motif Bio Plc-Locations And Subsidiaries 33

Head Office 33

Other Locations & Subsidiaries 33

Recent Developments 34

Financial Announcements 34

Sep 25, 2018: Motif Bio announces Half-Year 2018 financial results and operational progress 34

Apr 10, 2018: Motif Bio Reports Fiscal Year 2017 Results 35

Sep 29, 2017: Motif Bio reports half-year 2017 financial results and operational progress 39

May 01, 2017: Motif Bio Reports Year-End 2016 Financial Results 40

May 01, 2017: Motif Bio annual net loss up 41

Corporate Communications 42

Jul 03, 2018: Motif Bio Announces Resignation of Robert Bertoldi from Board of Directors 42

Feb 02, 2018: Motif Bio Appoints Jonathan E. Gold As Interim Chief Financial Officer 43

May 10, 2017: Motif Bio Appoints Scientific Opinion Leaders to Advisory Board 44

May 05, 2017: Motif Bio Appoints Dr. Craig Albanese as Non-Executive Director 45

Jan 17, 2017: Motif Bio: Appointment of Chief Financial Officer 46

Government and Public Interest 47

Jan 29, 2018: Motif Bio, Spero Therapeutics and Vical Join Antimicrobials Working Group 47

Product News 48

06/22/2017: Motif Bio Invited to Present at Infectious Diseases Conference 48

Clinical Trials 49

Aug 09, 2017: Motif Bio's second Phase 3 clinical trial in ABSSSI finishes patient treatment phase 49

Jul 06, 2017: Motif Bio to Present Three Posters at IDWeek 2017 50

May 01, 2017: Motif Bio Reports Year-end 2016 Financial Results 51

Apr 18, 2017: Motif Bio Announces Positive Results For Iclaprim, In The Revive-1 Phase 3 Study 52

Jan 30, 2017: Motif Bio Phase 3 Clinical Trial Finishes Patient Treatment Phase 53

Other Significant Developments 54

Mar 13, 2018: Motif Bio: Change of Registered Office 54

Appendix 55

Methodology 55

About GlobalData 55

Contact Us 55

Disclaimer 55


List Of Figure

List of Figures

Motif Bio Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Motif Bio Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Motif Bio Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Motif Bio Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Motif Bio Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Motif Bio Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Motif Bio Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Motif Bio Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9


List Of Table

List of Tables

Motif Bio Plc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Motif Bio Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Motif Bio Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Motif Bio Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Motif Bio Plc, Deals By Therapy Area, 2012 to YTD 2018 9

Motif Bio Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Motif Bio Enters into Agreement with Covance 11

Motif BioSciences Enters Into Co-Development Agreement With Jubilant Biosys 12

Motif Biosciences to Merge with Pharmaceutical Company 13

Motif Bio Raises USD13.5 Million in Private Placement of Shares 14

Motif Bio Raises Funds through Private Placement of Shares up on Exercise of Warrants 15

Motif Bio Raises Funds through Private Placement of Shares up on Exercise of Warrants 16

Motif Bio Files Registration Statement to Raise up to USD80 Million in Public Offering of Securities 17

Motif Bio Files Registration Statement to Raise Funds through Private Placement of ADS upon Exercise of Warrants 18

Motif Bio to Raise USD0.1 Million in Public Offering of Shares up on Exercise of Warrants 19

Motif Bio to Raise USD25 million in Placing of New Ordinary Shares 20

Motif Bio Raises Funds through Private Placement of Shares and Warrants 21

Motif Bio Raises USD17 Million in Public Offering of American Depositary Shares and Warrants 23

Motif Bio Raises Funds through Private Placement upon Exercise of Warrants 25

Motif Bio Raises Funds in Private Placement upon Exercise of Warrants 26

Motif Bio Raises USD35 Million in Private Placement of Shares 27

Motif Bio Raises USD41.8 Million in IPO 28

Motif Bio to Raise USD20 Million in Private Placement of Debt Financing 29

Motif BioSciences Acquires Nuprim 30

Motif Bio Plc, Key Competitors 31

Motif Bio Plc, Key Employees 32

Motif Bio Plc, Subsidiaries 33

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Motif Bio Plc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.